Psilocybin for Amblyopia - Targeting Critical Periods in Humans
Clinical trial registration, sponsored by Johns Hopkins University, registered 5 Nov 2026.
Phase 1/Phase 2 · recruiting · n = 24
Tags: Registry, Psilocybin.
Newly registered at Johns Hopkins: psilocybin alongside amblyopia therapy in adults, testing whether it reopens a visual critical period
How much weight it carries: Trial registry movements: what is being attempted, not what was found. (Registry, Plans, not results)
Read the original